Arkema Sa Stock Performance
| ARKAF Stock | USD 90.09 9.44 11.70% |
On a scale of 0 to 100, Arkema SA holds a performance score of 15. The firm shows a Beta (market volatility) of -1.72, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Arkema SA are expected to decrease by larger amounts. On the other hand, during market turmoil, Arkema SA is expected to outperform it. Please check Arkema SA's information ratio, value at risk, kurtosis, as well as the relationship between the sortino ratio and semi variance , to make a quick decision on whether Arkema SA's price patterns will revert.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Arkema SA are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite nearly unsteady basic indicators, Arkema SA reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 1.6 B | |
| Total Cashflows From Investing Activities | 473 M |
Arkema |
Arkema SA Relative Risk vs. Return Landscape
If you would invest 7,592 in Arkema SA on December 15, 2024 and sell it today you would earn a total of 1,417 from holding Arkema SA or generate 18.66% return on investment over 90 days. Arkema SA is currently producing 0.3668% returns and takes up 1.9183% volatility of returns over 90 trading days. Put another way, 17% of traded pink sheets are less volatile than Arkema, and 93% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Arkema SA Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Arkema SA's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Arkema SA, and traders can use it to determine the average amount a Arkema SA's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1912
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ARKAF | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.92 actual daily | 17 83% of assets are more volatile |
Expected Return
| 0.37 actual daily | 7 93% of assets have higher returns |
Risk-Adjusted Return
| 0.19 actual daily | 15 85% of assets perform better |
Based on monthly moving average Arkema SA is performing at about 15% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Arkema SA by adding it to a well-diversified portfolio.
Arkema SA Fundamentals Growth
Arkema Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Arkema SA, and Arkema SA fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Arkema Pink Sheet performance.
| Return On Equity | 0.15 | |||
| Return On Asset | 0.0333 | |||
| Profit Margin | 0.09 % | |||
| Operating Margin | 0.06 % | |||
| Current Valuation | 8.73 B | |||
| Shares Outstanding | 74.81 M | |||
| Price To Earning | 17.04 X | |||
| Price To Book | 0.79 X | |||
| Price To Sales | 0.59 X | |||
| Revenue | 9.52 B | |||
| EBITDA | 1.93 B | |||
| Cash And Equivalents | 1.34 B | |||
| Cash Per Share | 18.14 X | |||
| Total Debt | 2.56 B | |||
| Debt To Equity | 0.47 % | |||
| Book Value Per Share | 105.12 X | |||
| Cash Flow From Operations | 915 M | |||
| Earnings Per Share | 15.21 X | |||
| Total Asset | 12.3 B | |||
| Retained Earnings | 1.21 B | |||
| Current Asset | 3.4 B | |||
| Current Liabilities | 1.48 B | |||
About Arkema SA Performance
By analyzing Arkema SA's fundamental ratios, stakeholders can gain valuable insights into Arkema SA's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Arkema SA has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Arkema SA has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Arkema S.A. manufactures and sells specialty chemicals and advanced materials worldwide. Arkema S.A. was incorporated in 2003 and is headquartered in Colombes, France. Arkema operates under Specialty Chemicals classification in the United States and is traded on OTC Exchange. It employs 19441 people.Things to note about Arkema SA performance evaluation
Checking the ongoing alerts about Arkema SA for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Arkema SA help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Evaluating Arkema SA's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Arkema SA's pink sheet performance include:- Analyzing Arkema SA's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Arkema SA's stock is overvalued or undervalued compared to its peers.
- Examining Arkema SA's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Arkema SA's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Arkema SA's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Arkema SA's pink sheet. These opinions can provide insight into Arkema SA's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Arkema Pink Sheet analysis
When running Arkema SA's price analysis, check to measure Arkema SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arkema SA is operating at the current time. Most of Arkema SA's value examination focuses on studying past and present price action to predict the probability of Arkema SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arkema SA's price. Additionally, you may evaluate how the addition of Arkema SA to your portfolios can decrease your overall portfolio volatility.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |